Challenges of Drug Development in L-dopa-Naive Subjects with Diagnosis of Early Parkinson’s Disease
How to overcome hurdles in your early Parkinson's drug development
Tom Babic, M.D., Ph.D., presents his 2020 AD/PD session on challenges in early Parkinson’s drug development.
